August 9, 2021
Shardul Amarchand Mangaldas & Co. advised LeapFrog Investments (“LeapFrog”) in $31.1 million Series C round of investment in Medgenome Inc., which was led by International Finance Corporation.
The transaction team was led by Anuj Bhasme, Partner; Avichal Mathur, Principal Associate; Hardik Thakker, Senior Associate; and Shreeya Shukla, Associate.
Debevoise & Plimpton LLP advised LeapFrog on US aspects. Algo Legal advised Medgenome Inc.
Director - Corporate Communications
anil.nim@AMSShardul.com
The Bar Council of India does not permit solicitation of work and advertising by legal practitioners and advocates. By accessing the Shardul Amarchand Mangaldas & Co. website (our website), the user acknowledges that: